1. Home
  2. Analysis
  3. Lamotrigine
  4. Progressive-multifocal-leukoencephalopathy

Lamotrigine and Progressive multifocal leukoencephalopathy - a phase IV clinical study of FDA data

Summary:

Progressive multifocal leukoencephalopathy is reported as a side effect among people who take Lamotrigine (lamotrigine), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Tysabri, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Progressive multifocal leukoencephalopathy when taking Lamotrigine. It is created by eHealthMe based on reports of 72,834 people who have side effects when taking Lamotrigine from the FDA, and is updated regularly.

What is Lamotrigine?

Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 76,638 Lamotrigine users. Check the latest studies of Lamotrigine.

What is Progressive multifocal leukoencephalopathy?

Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells) is found to be associated with 595 drugs and 921 conditions by eHealthMe. Check the latest studies of Progressive multifocal leukoencephalopathy.

On Jul, 08, 2026

72,834 people reported to have side effects when taking Lamotrigine.
Among them, 36 people (0.05%) have Progressive multifocal leukoencephalopathy.

Could Lamotrigine cause Progressive multifocal leukoencephalopathy?

Among these 36 people:

How long have people been on Lamotrigine when they have Progressive multifocal leukoencephalopathy? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Progressive multifocal leukoencephalopathy when taking Lamotrigine? *

  • female: 66.67 %
  • male: 33.33 %

What is the age of people who have Progressive multifocal leukoencephalopathy when taking Lamotrigine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 6.06 %
  • 30-39: 42.42 %
  • 40-49: 21.21 %
  • 50-59: 15.15 %
  • 60+: 15.15 %

What are other drugs people take besides Lamotrigine? *

  1. Tysabri: 23 people, 63.89%
  2. Levetiracetam: 6 people, 16.67%
  3. Vitamin D: 6 people, 16.67%
  4. Baclofen: 6 people, 16.67%
  5. Sertraline Hydrochloride: 4 people, 11.11%
  6. Etodolac: 4 people, 11.11%
  7. Oxycontin: 4 people, 11.11%
  8. Keppra: 3 people, 8.33%
  9. Mirtazapine: 3 people, 8.33%
  10. Clopidogrel: 3 people, 8.33%

What are other side effects people have besides Progressive multifocal leukoencephalopathy? *

  1. Confusional State: 5 people, 13.89%
  2. Immune Reconstitution Syndrome (immune recovery syndrome): 5 people, 13.89%
  3. Nausea And Vomiting: 4 people, 11.11%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 11.11%
  5. Fainting (loss of consciousness and postural tone): 4 people, 11.11%
  6. Iron Deficiency Anaemia: 4 people, 11.11%
  7. Infarction (obstruction of the blood supply to an organ or region of tissue): 3 people, 8.33%
  8. Spinal Cord Disorder (disease of spinal cord): 3 people, 8.33%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 8.33%
  10. Gait Disturbance: 2 people, 5.56%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 25 people, 69.44%
  2. Pain: 5 people, 13.89%
  3. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 5 people, 13.89%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 11.11%
  5. Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 8.33%
  6. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 8.33%
  7. Depression: 3 people, 8.33%
  8. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.56%
  9. Psychotic Disorder: 2 people, 5.56%
  10. Muscle Spasms (muscle contraction): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lamotrigine and have Progressive multifocal leukoencephalopathy?

- Check whether Progressive multifocal leukoencephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamotrigine:

Progressive multifocal leukoencephalopathy treatments and more:

How severe was Progressive multifocal leukoencephalopathy and when was it recovered:

Expand to all the drugs that have ingredients of lamotrigine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamotrigine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Progressive multifocal leukoencephalopathy:

Browse all the conditions that are associated with Progressive multifocal leukoencephalopathy:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamotrigine) and Lamotrigine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.